Edesa Biotech, Inc. (EDSA)
EDSA Stock Price Chart
Explore Edesa Biotech, Inc. interactive price chart. Choose custom timeframes to analyze EDSA price movements and trends.
EDSA Company Profile
Discover essential business fundamentals and corporate details for Edesa Biotech, Inc. (EDSA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
21 Jun 2010
Employees
16.00
Website
https://www.edesabiotech.comCEO
Pardeep Nijhawan
Description
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
EDSA Financial Timeline
Browse a chronological timeline of Edesa Biotech, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 14 Aug 2026
EPS estimate is -$0.44.
Earnings released on 14 May 2026
EPS came in at -$0.49 falling short of the estimated -$0.24 by -104.17%.
Earnings released on 13 Feb 2026
EPS came in at -$0.28 matching the estimated -$0.28.
Earnings released on 12 Dec 2025
EPS came in at -$0.32 falling short of the estimated -$0.27 by -18.52%.
Earnings released on 8 Aug 2025
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%.
Earnings released on 14 May 2025
EPS came in at -$0.30 matching the estimated -$0.30.
Earnings released on 14 Feb 2025
EPS came in at -$0.48 falling short of the estimated -$0.31 by -54.84%.
Earnings released on 13 Dec 2024
EPS came in at -$0.29 surpassing the estimated -$0.54 by +46.30%.
Earnings released on 9 Aug 2024
EPS came in at -$0.52 surpassing the estimated -$0.58 by +10.34%.
Earnings released on 10 May 2024
EPS came in at -$0.58 surpassing the estimated -$0.69 by +15.94%.
Earnings released on 9 Feb 2024
EPS came in at -$0.54 surpassing the estimated -$1.21 by +55.37%.
Earnings released on 15 Dec 2023
EPS came in at -$0.60 surpassing the estimated -$0.71 by +15.49%, while revenue for the quarter reached -$1.12m .
Stock split effective on 11 Oct 2023
Shares were split 1 : 7 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Aug 2023
EPS came in at -$0.70 surpassing the estimated -$1.19 by +41.18%.
Earnings released on 11 May 2023
EPS came in at -$0.84 surpassing the estimated -$1.19 by +29.41%.
Earnings released on 10 Feb 2023
EPS came in at -$0.91 surpassing the estimated -$1.33 by +31.58%, while revenue for the quarter reached $1.12m .
Earnings released on 16 Dec 2022
EPS came in at -$0.07 surpassing the estimated -$2.80 by +97.50%.
Earnings released on 12 Aug 2022
EPS came in at -$2.59 falling short of the estimated -$2.52 by -2.78%.
Earnings released on 13 May 2022
EPS came in at -$2.31 surpassing the estimated -$2.59 by +10.81%.
Earnings released on 14 Feb 2022
EPS came in at -$2.31 surpassing the estimated -$2.80 by +17.50%.
Earnings released on 28 Dec 2021
EPS came in at -$1.89 surpassing the estimated -$2.59 by +27.03%, while revenue for the quarter reached -$3.51m .
Earnings released on 13 Aug 2021
EPS came in at -$2.52 falling short of the estimated -$2.24 by -12.50%.
EDSA Stock Performance
Access detailed EDSA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
